Diabetes conference sees protest, NIH endorsement, and GLP-1 data
7 reported
The American Diabetes Association’s annual conference in New Orleans concluded today after three days of data readouts and presentations. On Friday, half a dozen ADA members, including a past president, were reportedly escorted out of the convention center after attempting to hand out copies of an editorial criticizing Trump administration policies. The ADA’s media team told MedPage Today that the members violated code of conduct rules. That same afternoon, a senior adviser to the NIH endorsed the Make America Healthy Again movement in the conference’s keynote address, with NIH Director Jay Bhattacharya unable to attend due to a meeting with President Trump. The conference also featured GLP-1 drug news, including safety data on Eli Lilly’s next-gen obesity drug, mid-stage study data on Pfizer’s acquired obesity drug, and new data on Boehringer Ingelheim’s obesity drug.
What’s reported
The ADA conference in New Orleans wrapped up after three days.
On Friday, half a dozen ADA members, including a past president, were reportedly escorted out for handing out copies of an editorial critical of Trump administration policies.
The ADA’s media team said the members violated code of conduct rules.
The editorial was published by ADA’s own Diabetes Care journal.
A senior adviser to the NIH endorsed the Make America Healthy Again movement in the keynote address.
NIH Director Jay Bhattacharya was scheduled to give the keynote but had a last-minute substitute due to a meeting with President Trump.
GLP-1 drug news included safety data on Eli Lilly’s next-gen obesity drug, mid-stage data on Pfizer’s acquired obesity drug, and new data on Boehringer Ingelheim’s obesity drug.
Key figures
Jay Bhattacharya, NIH Director
Elizabeth Cooney, STAT reporter
Elaine Chen, STAT reporter
Helen Branswell, STAT reporter
Krutika Kuppalli, infectious disease doctor and former WHO medical officer
Tom Frieden, former CDC director
Sources: statnews.com
